# To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets

> **NCT00913809** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 36 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Desipramine HCL 100 mg Tablets Cord Laboratories
- **DRUG:** Norpramin 100 mg Tablets Merrell Dow Pharmaceuticals, Inc

## Key facts

- **NCT ID:** NCT00913809
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1987-12
- **Primary completion:** 1987-12
- **Final completion:** 1987-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00913809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00913809, "To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00913809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*